This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Turkcell, Teaching Note
Oberholzer-Gee, Felix; Wang, Charles C.Y.; Cekin, EselTeaching Note HBS-116040-EStrategyTeaching Note for case 115009.Starting at €0.00
-
UFO Moviez - Gentle Disruption
Luo, Hong; Oberholzer-Gee, Felix; Chaturvedi, SaloniCase HBS-716447-EStrategyUFO Moviez is an Indian technology services provider that enables low-cost, digital delivery of films to cinemas. UFO's satellite-based technology enables a significantly wider release of films compared to traditional analog prints and standard, higher-resolution digital prints that must be transported physically. By 2015, 54% of all cinemas in India were using UFO's digital cinema system. UFO has achieved this without upsetting the industry's va...Starting at €8.20
-
Intellectual Property Strategy at North Technology Group-Sailing Downwind
Oberholzer-Gee, Felix; Fisher, William W., IIICase HBS-714403-EStrategyTo maximize their effectiveness, color cases should be printed in color. North Sails is the world's leading sailmaker. The company commands a global market share of more than 50% and is largely responsible for the rapid technological progress in the sailmaking industry over the past 30 years. CEO Tom Whidden needs to consider how to best defend the company's leading position. Specifically, North currently uses neither patents nor copyright to pro...Starting at €8.20
-
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug, Teaching Note
Oberholzer-Gee, Felix; Yao, DennisTeaching Note HBS-707542-EStrategyTeaching note to 706454.Starting at €0.00
-
Brighter Smiles for the Masses--Colgate vs. P&G, Teaching Note
Oberholzer-Gee, Felix; Yao, DennisTeaching Note HBS-707545-EStrategyTeaching note to 706435.Starting at €0.00
-
Canyon Johnson Urban Fund, Teaching Note
Oberholzer-Gee, FelixTeaching Note HBS-707546-EStrategyTeaching note to 706442.Starting at €0.00
-
Red Flag Software Co., Teaching Note
Oberholzer-Gee, FelixTeaching Note HBS-707547-EStrategyTeaching note to 706428.Starting at €0.00
-
UBS and Climate Change--Warming Up to Global Action?
Oberholzer-Gee, Felix; Reinhardt, Forest L.; Raabe, Elizabeth A.Case HBS-707511-ELeadership and People ManagementMarco Suter, Executive Vice-Chairman, UBS Board of Directors, carefully studied the chart on his desk. It showed the public commitment of major financial institutions to help mitigate global warming. Evidently, UBS lagged behind its competitors. The graph was part of a report that environmental specialists and senior executives at UBS had compiled. It suggested the company adopt a more progressive policy on climate change. Suter thought about the...Starting at €8.20
-
The Limits of Scale
Halaburda, Hanna; Oberholzer-Gee, FelixArticle HBS-R1404G-EStrategyThe value of many products and services rises or falls with the number of customers using them; the fewer fax machines in use, the less important it is to have one. These network effects influence consumer decisions and affect companies' ability to compete. Strategists have developed some well-known rules for navigating business environments with network effects. "Move first" is one, and "get big fast" is another. In a study of dozens of companie...Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20